Back to Search
HARRIS GELBARD, MD
MD
Neurology with Special Qualifications in Child Neurology Physician
NPI: 1760414528Individual
Specialties, Licenses & Credentials
Neurology with Special Qualifications in Child Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
178553(NY)
Research & Publications (20)
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.
PMID 19541372·J Neuroimmunol·2009
7-preclinical
Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment.
PMID 19306230·J Neurovirol·2009
8-other
HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.
PMID 19009018·PLoS One·2008
7-preclinical
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir.
PMID 18573930·Antimicrob Agents Chemother·2008
8-other
Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
PMID 17312171·J Immunol·2007
8-other
Extrinsic and intrinsic systems in the posterior cortex of the human brain revealed during natural sensory stimulation.
PMID 16699080·Cereb Cortex·2007
8-other
HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons.
PMID 17202348·J Immunol·2007
7-preclinical
The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation.
PMID 18040844·J Neuroimmune Pharmacol·2007
4-observational
Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.
PMID 18040831·J Neuroimmune Pharmacol·2007
6-review
Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation.
PMID 16785569·J Immunol·2006
7-preclinical
Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.
PMID 16817865·Eur J Neurosci·2006
7-preclinical
Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.
PMID 18040788·J Neuroimmune Pharmacol·2006
6-review
Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.
PMID 16510768·Neurology·2006
4-observational
Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.
PMID 16162919·J Neurosci·2005
7-preclinical
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
PMID 16276420·J Clin Invest·2005
7-preclinical
Coupling between neuronal firing, field potentials, and FMRI in human auditory cortex.
PMID 16081741·Science·2005
8-other
Adjunctive therapies for HIV-1 associated neurologic disease.
PMID 16260393·Neurotox Res·2005
6-review
HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis.
PMID 15778398·J Immunol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 275-2808
Quick Facts
- NPI
- 1760414528
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile